by Cristóbal Coronel-Rodríguez  and Alejandro Rodríguez-Martínez

Received: 07 May 2020;  Published: 17 July 2020;  doi: 10.21926/obm.neurobiol.2003066

Gluten-related disorders (GRDs) represent a spectrum of diverse clinical manifestations triggered by the ingestion of gluten in genetically susceptible individuals. The most common and widely recognized diseases within this spectrum are celiac disease and non-celiac gluten sensitivity. The clinical manifestations are intestinal, but extraintestinal manifestations may also appear, such as neurological or psychiatric. This work will specifically review the neurological or psychiatric manifestations that are more fre [...]

by Jamie Zhen  and M Ines Pinto-Sanchez

Received: 17 May 2020;  Published: 10 July 2020;  doi: 10.21926/obm.neurobiol.2003065

Celiac disease (CeD) is an immune-mediated enteropathy triggered by gluten ingestion and affects nearly 1% of the population worldwide. CeD has typically been associated with gastrointestinal symptoms such as diarrhea and abdominal pain; however, its extra-intestinal manifestations are becoming widely recognized. In particular, CeD patients may present with various neurological manifestations and oftentimes, without evidence of gastrointestinal symptoms. The pathophysiology behind these manifestations is not well k [...]

by Ian W. Stone  , Ashim Gupta  , Hugo C. Rodriguez  , R. Justin Mistovich  , Manu Gupta  , Anish G. Potty  and Jorge R. Serrato

Received: 03 May 2020;  Published: 24 June 2020;  doi: 10.21926/obm.neurobiol.2002064

Obesity is on the rise around the world, carrying along with it a wide range of comorbidities and complications. We report on a super-super morbidly obese 43-year-old female, with a body mass index (BMI) of 77.85 kg/m2 (173cm, 233kg), who presented for a scheduled suboccipital craniectomy with C-1 laminectomy secondary to symptoms from an Arnold-Chiari type-I malformation. Already a challenging type of surgery, due to the patient’s extreme BMI and positioning, the surgery became more difficult. There are many poten [...]

by Debora Di Jorio

Received: 14 April 2020;  Published: 22 June 2020;  doi: 10.21926/obm.neurobiol.2002063

The story of each individual is essentially the story of theirlearning processes and relationships from the moment they were born. Indeed, the story of learning processes is merely a constant stratification of experiences based on biological and neurofunctional features that are influenced by genetic and cultural factors and subject to environmental stimuli constantly reshaping their behavior. Neuroscientific studies conducted over the past decades have highlighted a unique feature of the human nervous system, cal [...]

by Clarissa E.H. Fang  , Li Guo  , Daniel Hill  , Timothy E. Yap  and M. Francesca Cordeiro

Received: 16 April 2020;  Published: 15 June 2020;  doi: 10.21926/obm.neurobiol.2002062

Neuroprotection in glaucoma is any medical treatment by which decline in visual function can be slowed or prevented by supporting the health and survival of neural cells, independent of lowering of intraocular pressure (IOP). This is achieved by targeting mechanisms to inhibit or delay retinal ganglion cell death and promote cell survival pathways. Despite demonstrating promising results in preclinical trials, many neuroprotective strategies have failed to show success in subsequent clinical trials. Of the clinical [...]

by Tania Re  and Giuseppe Vitiello

Received: 30 April 2020;  Published: 11 June 2020;  doi: 10.21926/obm.neurobiol.2002061

The present report discusses brain visual experiences in conditions of low degree of openness of the brain toward the environment, for example, while dreaming, during meditation, or in non-ordinary brain activity states such as under the effects of psychoactive substances, in the state of coma, or in other states of reduced sensory perception, among others. In the present report, for brevity, such states are referred to as brain-mind visual experiences, implying that such a visual activity is not one connected to t [...]

by Ioannis Syros  , Panagiota Pervanidou  , Charis Liapi  , Filia Apostolakou  , George P Chrousos  and Gerasimos Kolaitis

Received: 01 March 2020;  Published: 11 June 2020;  doi: 10.21926/obm.neurobiol.2002060

Data available on possible associations of lipids, steroid levels, and depression are conflicting. This study investigated their possible associations in a sample of youth with depression. Ninety-eight youth with depression and individually matched healthy volunteers on the basis of age and sex were enrolled for the study. The two groups had nearly similar body mass index. After fasting overnight, they underwent blood sampling for triglycerides (TG), total cholesterol, low-density lipoprotein, high-density lipoprot [...]

by Yuan Liang  , Yu Zheng  , Brighty Renli  , David C. Zhu  , Fang Yu  and Tongtong Li

Received: 29 September 2019;  Published: 01 June 2020;  doi: 10.21926/obm.neurobiol.2002059

In this paper, motivated by the fading effect in wireless communications, where severe channel fading is related to information loss during the transmission, we evaluate and analyze the fading effect in time-varying functional connectivity of AD, MCI and NC subjects based on the resting-state fMRI data, and then apply that for AD, MCI, NC classification. We show that in some critical brain regions, compared with NC subjects, AD subjects suffer more severe and long lasting fading in the functional connectivity level [...]

by Vincenza Rita Lo Vasco

Received: 01 October 2019;  Published: 18 May 2020;  doi: 10.21926/obm.neurobiol.2002058

Mechanisms leading to neuronal cell death in human pathology are far from being fully delineated. Understanding the molecules involved in neuronal death and the timing of their recruitment might help to explain the natural history of degenerative processes, including the morphological abnormalities observed in Alzheimer’s disease (AD). Moreover, it might help refine the diagnosis by defining new molecular markers as well as find effective therapies, especially for slow cognitive deficits, often associated with neur [...]

by Helena M. Minye

Received: 06 February 2020;  Published: 18 May 2020;  doi: 10.21926/obm.neurobiol.2002057

Temporomandibular disorders (TMD) are a group of musculoskeletal and neuromuscular conditions that involve the temporomandibular joint (TMJ), the masticatory muscles, and branches of the trigeminal nerve. TMD is the most common chronic oral facial pain disorder. Pain associated with TMD can be clinically expressed as myogenous or arthrogenous in etiology. The myogenous variant of TMD is characterized by pain in the muscles of mastication. The arthrogenous form of TMD is caused by pain in the joint leading to synovi [...]